Additionally, enhancements in hyperlipidemia and diabetes within obese mice, mainly down‐regulation of PPAR‐γ and SREBP‐1c increased lipid metabolism in order to show beneficial effects in cholesterol levels (Zang et al. 2015). The gene discussed is PPARG; the disease is hyperlipidemia.